AMERISAFE Capital Surpluse vs Current Deferred Revenue Analysis
AMSF Stock | USD 44.38 0.70 1.55% |
AMERISAFE financial indicator trend analysis is way more than just evaluating AMERISAFE prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AMERISAFE is a good investment. Please check the relationship between AMERISAFE Capital Surpluse and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.
Capital Surpluse vs Current Deferred Revenue
Capital Surpluse vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AMERISAFE Capital Surpluse account and Current Deferred Revenue. At this time, the significance of the direction appears to have very strong relationship.
The correlation between AMERISAFE's Capital Surpluse and Current Deferred Revenue is 0.81. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of AMERISAFE, assuming nothing else is changed. The correlation between historical values of AMERISAFE's Capital Surpluse and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of AMERISAFE are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Capital Surpluse i.e., AMERISAFE's Capital Surpluse and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.81 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Capital Surpluse
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from AMERISAFE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AMERISAFE current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.The AMERISAFE's current Tax Provision is estimated to increase to about 17.9 M, while Selling General Administrative is projected to decrease to roughly 24.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 265.2M | 244.1M | 306.9M | 291.0M | Total Revenue | 316.0M | 294.7M | 306.9M | 329.6M |
AMERISAFE fundamental ratios Correlations
Click cells to compare fundamentals
AMERISAFE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AMERISAFE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.5B | 1.5B | 1.4B | 1.3B | 1.2B | 1.2B | |
Total Stockholder Equity | 430.2M | 438.8M | 399.3M | 317.4M | 292.5M | 299.4M | |
Property Plant And Equipment Net | 6.3M | 6.5M | 6.7M | 7.3M | 6.3M | 7.2M | |
Net Debt | (43.3M) | (61.3M) | (70.3M) | (61.1M) | (38.4M) | (40.3M) | |
Retained Earnings | 227.2M | 224.6M | 190.5M | 145.5M | 114.3M | 152.8M | |
Non Current Assets Total | 1.1B | 1.1B | 1.0B | 896.3M | 864.1M | 907.3M | |
Non Currrent Assets Other | (1.1B) | (1.1B) | (1.0B) | (40.2M) | (864.1M) | (907.3M) | |
Other Assets | 63.9M | 51.3M | 57.1M | (281.0M) | (263.6M) | (250.4M) | |
Cash And Short Term Investments | 43.8M | 61.8M | 70.7M | 61.5M | 355.7M | 373.5M | |
Net Receivables | 253.9M | 262.6M | 255.7M | 247.4M | 272.9M | 252.4M | |
Common Stock Shares Outstanding | 19.3M | 19.4M | 19.4M | 19.3M | 19.2M | 16.9M | |
Short Term Investments | 497.7M | 460.2M | 399.2M | 335.2M | 317.1M | 346.9M | |
Liabilities And Stockholders Equity | 1.5B | 1.5B | 1.4B | 1.3B | 1.2B | 1.2B | |
Non Current Liabilities Total | 1.1B | 1.0B | 997.0M | 38.1M | 271.6M | 258.0M | |
Other Stockholder Equity | 190.6M | 192.9M | 195.1M | 185.5M | 185.1M | 164.0M | |
Total Liab | 40.1M | 38.9M | 37.9M | 951.8M | 815.6M | 806.1M | |
Property Plant And Equipment Gross | 6.1M | 6.3M | 6.3M | 6.5M | 7.5M | 7.1M | |
Total Current Assets | 297.7M | 324.3M | 326.4M | 654.0M | 628.6M | 433.5M | |
Cash | 43.8M | 61.8M | 70.7M | 61.5M | 38.7M | 65.1M | |
Other Current Liab | (40.1M) | (38.9M) | (37.9M) | (22.8M) | 544.0M | 571.2M | |
Total Current Liabilities | 40.1M | 38.9M | 37.9M | 38.1M | 544.0M | 571.2M | |
Other Liab | 642.5M | 902.8M | 882.3M | 798.8M | 918.6M | 468.7M | |
Accounts Payable | 40.1M | 38.9M | 37.9M | 38.1M | 43.8M | 32.9M | |
Long Term Debt | 37.9M | 43.4M | 42.9M | 48.8M | 56.1M | 38.6M | |
Accumulated Other Comprehensive Income | 12.2M | 21.0M | 13.5M | (13.8M) | (7.2M) | (6.8M) | |
Property Plant Equipment | 6.3M | 6.2M | 6.5M | 7.2M | 8.3M | 7.2M | |
Other Current Assets | 345.2M | 397.9M | 379.9M | 276.9M | 271.6M | 298.6M | |
Net Tangible Assets | 430.2M | 438.8M | 399.3M | 317.4M | 285.7M | 328.5M | |
Good Will | 1.1B | 1.1B | 987.8M | 816.9M | 939.4M | 986.4M | |
Retained Earnings Total Equity | 227.2M | 224.6M | 190.5M | 145.5M | 131.0M | 179.9M | |
Long Term Debt Total | 37.9M | 43.4M | 42.9M | 48.8M | 56.1M | 43.7M | |
Capital Surpluse | 213.0M | 215.3M | 217.5M | 220.3M | 253.3M | 226.0M | |
Inventory | (345.2M) | (397.9M) | (379.9M) | 68.2M | (271.6M) | (258.0M) | |
Long Term Investments | 1.1B | 1.1B | 1.0B | 897.4M | 857.8M | 1.1B | |
Non Current Liabilities Other | 1.0B | 988.2M | 960.5M | 903.0M | 1.0B | 1.1B | |
Intangible Assets | 19.0M | 17.8M | 17.1M | 17.4M | 18.0M | 19.1M |
Currently Active Assets on Macroaxis
MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce | |
MSFT | Microsoft | |
GOOG | Alphabet Inc Class C |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for AMERISAFE Stock analysis
When running AMERISAFE's price analysis, check to measure AMERISAFE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AMERISAFE is operating at the current time. Most of AMERISAFE's value examination focuses on studying past and present price action to predict the probability of AMERISAFE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AMERISAFE's price. Additionally, you may evaluate how the addition of AMERISAFE to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is AMERISAFE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AMERISAFE. If investors know AMERISAFE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AMERISAFE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.02) | Dividend Share 1.39 | Earnings Share 3.21 | Revenue Per Share 16.136 | Quarterly Revenue Growth 0.026 |
The market value of AMERISAFE is measured differently than its book value, which is the value of AMERISAFE that is recorded on the company's balance sheet. Investors also form their own opinion of AMERISAFE's value that differs from its market value or its book value, called intrinsic value, which is AMERISAFE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AMERISAFE's market value can be influenced by many factors that don't directly affect AMERISAFE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AMERISAFE's value and its price as these two are different measures arrived at by different means. Investors typically determine if AMERISAFE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AMERISAFE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.